mohamadraffiwahab

mohamadraffiwahab

Any rising is a selling opportunity...more downside possible...another one - two year of pain

mohamadraffiwahab

IGA ...Oral TPOXX® (tecovirimat) is the first drug approved by the U.S. Food and Drug Administration (FDA) that is specifically indicated for the treatment of smallpox disease in adults and pediatric patients weighing at least 13 kg. (,,More than $1 billion in contract value awarded by the U.S. government

mohamadraffiwahab

planning to add moneygram in coming months..oversold on daily will add if 5 level holds... ..tgt 15-17

mohamadraffiwahab

Not Looking good....if channel broke i will wait another 1 and half year to enter long @ 2.00

mohamadraffiwahab

oversold possiblity of reversal..target 14....if support holds planning to enter long

mohamadraffiwahab

after breakout ...4 leg strategy Estimated returns As at 3rd Oct 2021 (BA $226.17) Entry cost: $248.00 see details Maximum risk: $248.00 (at BA$225.00) Maximum return: $502.00 (at BA$232.50) Max return on risk: 202.4% (12314% ann.) Breakevens at expiry: $227.48 Probability of profit: 44.6% ? 225 ce +240 ce buy 232.5-& 235 ce short

mohamadraffiwahab

falling wedge..good time to invest..this one will double after pandemic

mohamadraffiwahab

Facing resistance..rejection from top can go for short

mohamadraffiwahab

sell on rise ..trading inside triangle if price rejects @ top go for short

mohamadraffiwahab

Add On Dips Trading Inside Channel..Add in SIP Till 282

mohamadraffiwahab

Falling wedge

mohamadraffiwahab

falling wedge

mohamadraffiwahab

weekly breakout

mohamadraffiwahab

TRADES ABOVE REDLINE CAN ENTER LONG

mohamadraffiwahab

TGT 1.40-2.90

mohamadraffiwahab

GOOD DIVIDEND STOCK BUY NEAR PURPLE LINE

mohamadraffiwahab

if price rejects @ top planning to buy sep 70 pe for tgt 49...trades above channel view negated

mohamadraffiwahab

TGT 42